These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 2994986)
21. Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group. Gavras I; Gavras H Curr Med Res Opin; 1999; 15(1):15-24. PubMed ID: 10216807 [TBL] [Abstract][Full Text] [Related]
22. Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system. Dahlöf B; Herlitz H; Aurell M; Hansson L Am J Hypertens; 1992 Dec; 5(12 Pt 1):900-11. PubMed ID: 1337459 [TBL] [Abstract][Full Text] [Related]
23. Enalapril: a review of human pharmacology. Gomez HJ; Cirillo VJ; Irvin JD Drugs; 1985; 30 Suppl 1():13-24. PubMed ID: 2994984 [TBL] [Abstract][Full Text] [Related]
24. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension. Valvo E; Gammaro L; Bedogna V; Tonon M; Giorgetti P; Pica B; Antonini P; Tessitore N; Oldrizzi L; Rugiu C Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196 [TBL] [Abstract][Full Text] [Related]
25. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension. Franklin SS; Smith RD Am J Med; 1985 Sep; 79(3C):14-23. PubMed ID: 2996342 [TBL] [Abstract][Full Text] [Related]
26. [The acute effects of the new angiotensin I-converting enzyme inhibitor, enalapril maleate, on blood pressure, plasma renin, aldosterone and kinins in hypertensive patients]. Gotoh M; Mizuno K; Hashimoto S; Kunii N; Fukuchi S Nihon Naibunpi Gakkai Zasshi; 1985 May; 61(5):619-29. PubMed ID: 2991035 [TBL] [Abstract][Full Text] [Related]
27. Comparative studies: enalapril versus hydrochlorothiazide as first-step therapy for the treatment of primary hypertension. Bauer JH; Jones LB Am J Kidney Dis; 1984 Jul; 4(1):55-62. PubMed ID: 6331157 [TBL] [Abstract][Full Text] [Related]
28. Double-blind comparison of captopril and enalapril in mild to moderate hypertension. Vlasses PH; Conner DP; Rotmensch HH; Fruncillo RJ; Danzeisen JR; Shepley KJ; Ferguson RK J Am Coll Cardiol; 1986 Mar; 7(3):651-60. PubMed ID: 3005384 [TBL] [Abstract][Full Text] [Related]
29. Lipid profile during antihypertensive treatment. The SLIP Study Group. Study on Lipids with Isoptin Press. Libretti A; Catalano M Drugs; 1993; 46 Suppl 2():16-23. PubMed ID: 7512469 [TBL] [Abstract][Full Text] [Related]
30. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. Jensen J; Henik RA; Brownfield M; Armstrong J Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564 [TBL] [Abstract][Full Text] [Related]
31. Effects of enalapril, a new converting enzyme inhibitor, in hypertension. Ferguson RK; Vlasses PH; Swanson BN; Mojaverian P; Hichens M; Irvin JD; Huber PB Clin Pharmacol Ther; 1982 Jul; 32(1):48-53. PubMed ID: 6282527 [TBL] [Abstract][Full Text] [Related]
32. Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension? Wu RA; Kailasam MT; Cervenka JH; Parmer RJ; Kennedy BP; Ziegler MG; O'Connor DT J Hypertens; 1994 Nov; 12(11):1243-7. PubMed ID: 7868871 [TBL] [Abstract][Full Text] [Related]
33. Treatment of mild to moderate hypertension with or without the converting enzyme inhibitor enalapril. Results of a six-month double-blind trial. Sassano P; Chatellier G; Billaud E; Alhenc-Gelas F; Corvol P; Ménard J Am J Med; 1987 Aug; 83(2):227-35. PubMed ID: 3039842 [TBL] [Abstract][Full Text] [Related]
34. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects. Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164 [TBL] [Abstract][Full Text] [Related]
35. [Antihypertensive effectiveness of enalapril and hydrochlorothiazide as a combination drug]. Pirich C; Banyai M Wien Med Wochenschr; 1993; 143(11):290-3. PubMed ID: 8212715 [TBL] [Abstract][Full Text] [Related]
36. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide. Guerrero P; Fuchs FD; Moreira LM; Martins VM; Bertoluci C; Fuchs SC; Gus M Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259 [TBL] [Abstract][Full Text] [Related]
37. Treatment of essential hypertension in Asians: enalapril as monotherapy versus combination therapy with hydrochlorothiazide. Jones DW; Sands CD Pharmacotherapy; 1991; 11(2):127-30. PubMed ID: 2052467 [TBL] [Abstract][Full Text] [Related]
38. An overview of the clinical pharmacology of enalapril. Davies RO; Gomez HJ; Irvin JD; Walker JF Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):215S-229S. PubMed ID: 6099737 [TBL] [Abstract][Full Text] [Related]
39. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM. Chan JC; Nicholls MG; Cheung CK; Law LK; Swaminathan R; Cockram CS Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530 [TBL] [Abstract][Full Text] [Related]
40. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence. Antza C; Stabouli S; Kotsis V Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]